{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:29:18Z","timestamp":1786652958327,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.physbeh.2026.115470","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:31:15Z","timestamp":1786548675000},"page":"115470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rimonabant reveals reward- and anxiety-related behavioral effects of N-arachidonoyl dopamine (N-ADA) in mice"],"prefix":"10.1016","author":[{"given":"Oliver A.","family":"Colis-Arenas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya Ch.","family":"Navarro-Montellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos H.","family":"L\u00f3pez-Lariz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Romero-Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0244-5209","authenticated-orcid":false,"given":"Bruno A. Marichal","family":"Cancino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.physbeh.2026.115470_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020622","article-title":"GPR55 Receptor Activation by the N-Acyl Dopamine Family Lipids Induces Apoptosis in Cancer Cells via the Nitric Oxide Synthase (nNOS) Over-Stimulation","volume":"22","author":"Akimov","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.physbeh.2026.115470_bib0002","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1074\/jbc.M111.296020","article-title":"Modulation of L-\u03b1-lysophosphatidylinositol\/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids","volume":"287","author":"Anavi-Goffer","year":"2012","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.physbeh.2026.115470_bib0003","article-title":"Role of GPR55 in glutamatergic and dopaminergic signaling: A review of preclinical evidence in neuropsychiatric disorders","volume":"108","author":"Awathale","year":"2026","journal-title":"Molecular Pharmacology"},{"issue":"4","key":"10.1016\/j.physbeh.2026.115470_bib0004","first-page":"199","article-title":"Revised Guide for the Care and Use of Laboratory Animals available. American Physiological Society","volume":"39","author":"Bayne","year":"1996","journal-title":"Physiologist"},{"issue":"Pt 3","key":"10.1016\/j.physbeh.2026.115470_bib0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1042\/bj3510817","article-title":"N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo","volume":"351","author":"Bisogno","year":"2000","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/j.physbeh.2026.115470_bib0006","first-page":"7","article-title":"Possible involvement of dorsal hippocampal G-protein coupled receptor 55 (GPR55) in nicotine-induced conditioned place preference in rats","volume":"30","author":"Colis-Arenas","year":"2026","journal-title":"Archivos de Neurociencias"},{"issue":"1","key":"10.1016\/j.physbeh.2026.115470_bib0007","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41398-025-03644-5","article-title":"Cannabinoid CB1 receptor in dopaminergic circuit from ventral tegmental area to nucleus accumbens links trait anxiety with reward learning","volume":"15","author":"Cui","year":"2025","journal-title":"Translational Psychiatry"},{"issue":"4","key":"10.1016\/j.physbeh.2026.115470_bib0008","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0959-4388(02)00340-9","article-title":"Endovanilloid signaling in pain","volume":"12","author":"Di Marzo","year":"2002","journal-title":"Current opinion in neurobiology"},{"issue":"3","key":"10.1016\/j.physbeh.2026.115470_bib0009","doi-asserted-by":"crossref","first-page":"304","DOI":"10.55782\/ane-2022-029","article-title":"Central GPR55 may prevent nicotine reinforcing actions: a preliminary study","volume":"82","author":"D\u00edaz-Barba","year":"2022","journal-title":"Acta Neurobiol Exp (Wars)"},{"issue":"1","key":"10.1016\/j.physbeh.2026.115470_bib0010","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1038\/s41467-023-42283-6","article-title":"The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption","volume":"14","author":"Ding","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/j.physbeh.2026.115470_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108554","article-title":"Gabapentin attenuates somatic signs of precipitated THC withdrawal in mice","volume":"190","author":"Eckard","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2026.115470_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172966","article-title":"Precipitated \u03949-THC withdrawal reduces motivation for sucrose reinforcement in mice","volume":"195","author":"Eckard","year":"2020","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.physbeh.2026.115470_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2025.114929","article-title":"The endocannabinoid and paracannabinoid systems in natural reward processes: possible pharmacological targets?","volume":"296","author":"Friuli","year":"2025","journal-title":"Physiology & Behavior"},{"issue":"9","key":"10.1016\/j.physbeh.2026.115470_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/genes7090056","article-title":"Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model","volume":"7","author":"Gomis-Gonz\u00e1lez","year":"2016","journal-title":"Genes (Basel)"},{"issue":"12","key":"10.1016\/j.physbeh.2026.115470_bib0015","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/nn.2685","article-title":"Postsynaptic TRPV1 triggers cell type\u2013specific long-term depression in the nucleus accumbens","volume":"13","author":"Grueter","year":"2010","journal-title":"Nature Neuroscience"},{"issue":"3","key":"10.1016\/j.physbeh.2026.115470_bib0016","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1523\/JNEUROSCI.1493-22.2022","article-title":"Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in Mice","volume":"43","author":"Han","year":"2023","journal-title":"J Neurosci"},{"issue":"12","key":"10.1016\/j.physbeh.2026.115470_bib0017","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1073\/pnas.122196999","article-title":"An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors","volume":"99","author":"Huang","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.physbeh.2026.115470_bib0018","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","article-title":"Drug addiction, dysregulation of reward, and allostasis","volume":"24","author":"Koob","year":"2001","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.physbeh.2026.115470_bib0019","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/jm980363y","article-title":"Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists","volume":"42","author":"Lan","year":"1999","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.physbeh.2026.115470_bib0020","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.0711278105","article-title":"GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current","volume":"105","author":"Lauckner","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.physbeh.2026.115470_bib0021","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.4049\/jimmunol.1602151","article-title":"N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via Nonhematopoietic TRPV1","volume":"199","author":"Lawton","year":"2017","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"issue":"5","key":"10.1016\/j.physbeh.2026.115470_bib0022","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1248\/bpb.b15-00834","article-title":"Cannabinoid-Elicited Conditioned Place Preference in a Modified Behavioral Paradigm","volume":"39","author":"Liu","year":"2016","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"10.1016\/j.physbeh.2026.115470_bib0023","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/1570159X14666160729155441","article-title":"Advances in the Physiology of GPR55 in the Central Nervous System","volume":"15","author":"Marichal-Cancino","year":"2017","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"10.1016\/j.physbeh.2026.115470_bib0024","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1523\/JNEUROSCI.3303-06.2007","article-title":"Reduced Anxiety, Conditioned Fear, and Hippocampal Long-Term Potentiation in Transient Receptor Potential Vanilloid Type 1 Receptor-Deficient Mice","volume":"27","author":"Marsch","year":"2007","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.physbeh.2026.115470_bib0025","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbr.2013.05.023","article-title":"Anxiogenic-like effect induced by TRPV1 receptor activation within the dorsal periaqueductal gray matter in mice","volume":"250","author":"Mascarenhas","year":"2013","journal-title":"Behavioural Brain Research"},{"issue":"1","key":"10.1016\/j.physbeh.2026.115470_bib0026","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00213-015-4092-x","article-title":"CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats","volume":"233","author":"McReynolds","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2026.115470_bib0027","doi-asserted-by":"crossref","unstructured":"Moore, C.F., Weerts, E.M., 2025. Effects of sex and pre-exposure on \u03949-tetrahydrocannabinol (THC) vapor self-administration in rats. bioRxiv.","DOI":"10.1101\/2025.08.01.668172"},{"key":"10.1016\/j.physbeh.2026.115470_bib0028","series-title":"Cannabis Use, Neurobiology, Psychology, and Treatment","first-page":"395","article-title":"Chapter 29 - Linking the G-protein-coupled receptor 55 (GPR55) to the cannabinoid receptors (CB1 and CB2): A new narrative","author":"Morales","year":"2023"},{"key":"10.1016\/j.physbeh.2026.115470_bib0029","series-title":"Test No. 412: Subacute Inhalation Toxicity: 28-Day Study, OECD Guidelines for the Testing of Chemicals, Section 4","year":"2018"},{"issue":"7","key":"10.1016\/j.physbeh.2026.115470_bib0030","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLOS Biology"},{"issue":"1-3","key":"10.1016\/j.physbeh.2026.115470_bib0031","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"2-3","key":"10.1016\/j.physbeh.2026.115470_bib0032","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","article-title":"SR141716A, a potent and selective antagonist of the brain cannabinoid receptor","volume":"350","author":"Rinaldi-Carmona","year":"1994","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.physbeh.2026.115470_bib0033","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/adb.12508","article-title":"Pooled analysis of three randomized, double-blind, placebo controlled trials with rimonabant for smoking cessation","volume":"23","author":"Robinson","year":"2018","journal-title":"Addict Biol"},{"issue":"5","key":"10.1016\/j.physbeh.2026.115470_bib0034","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.bjp.0705467","article-title":"Anandamide and vanilloid TRPV1 receptors","volume":"140","author":"Ross","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1016\/j.physbeh.2026.115470_bib0035","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"96","key":"10.1016\/j.physbeh.2026.115470_bib0036","doi-asserted-by":"crossref","DOI":"10.3791\/52434-v","article-title":"Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice","author":"Seibenhener","year":"2015","journal-title":"J Vis Exp"},{"issue":"3","key":"10.1016\/j.physbeh.2026.115470_bib0037","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pharmthera.2010.02.004","article-title":"Pharmacological characterization of GPR55, a putative cannabinoid receptor","volume":"126","author":"Sharir","year":"2010","journal-title":"Pharmacology & therapeutics"},{"key":"10.1016\/j.physbeh.2026.115470_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104545","article-title":"Neuropsychiatric implications of transient receptor potential vanilloid (TRPV) channels in the reward system","volume":"131","author":"Singh","year":"2019","journal-title":"Neurochemistry International"},{"issue":"11","key":"10.1016\/j.physbeh.2026.115470_bib0039","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/s41386-024-01861-y","article-title":"AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects","volume":"49","author":"Soler-Cede\u00f1o","year":"2024","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.physbeh.2026.115470_bib0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.31887\/DCNS.2020.22.3\/rspanagel","article-title":"Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions","volume":"22","author":"Spanagel","year":"2020","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"10.1016\/j.physbeh.2026.115470_bib0041","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1124\/jpet.110.168435","article-title":"Rimonabant-Induced \u03949-Tetrahydrocannabinol Withdrawal in Rhesus Monkeys: Discriminative Stimulus Effects and Other Withdrawal Signs","volume":"334","author":"Stewart","year":"2010","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/j.physbeh.2026.115470_bib0042","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.euroneuro.2008.11.004","article-title":"Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray","volume":"19","author":"Terzian","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.physbeh.2026.115470_bib0043","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s41598-018-19207-2","article-title":"Blockade of TRPV1 Inhibits Methamphetamine-induced Rewarding Effects","volume":"8","author":"Tian","year":"2018","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/j.physbeh.2026.115470_bib0044","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41398-025-03388-2","article-title":"The role of reward-related brain activity in response to treatment and later depression severity: data from a randomized controlled trial in early adolescents with anxiety disorders","volume":"15","author":"Westbrook","year":"2025","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10.1016\/j.physbeh.2026.115470_bib0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pbb.2006.07.018","article-title":"SR 141716 (Rimonabant) precipitates withdrawal in marijuana-dependent mice","volume":"85","author":"Wilson","year":"2006","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.physbeh.2026.115470_bib0046","article-title":"GPR55 is expressed in glutamate neurons and functionally modulates nicotine taking and seeking in rats and mice","author":"Xi","year":"2023","journal-title":"Res Sq."},{"issue":"1","key":"10.1016\/j.physbeh.2026.115470_bib0047","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbr.2010.10.008","article-title":"Effects of cannabinoid CB1 receptor antagonist rimonabant on acquisition and reinstatement of psychostimulant reward memory in mice","volume":"217","author":"Yu","year":"2011","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.physbeh.2026.115470_bib0048","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuropharm.2014.10.008","article-title":"Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner","volume":"89","author":"Z\u00e1dor","year":"2015","journal-title":"Neuropharmacology"}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938426002532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938426002532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:28:51Z","timestamp":1786649331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938426002532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":48,"alternative-id":["S0031938426002532"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2026.115470","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rimonabant reveals reward- and anxiety-related behavioral effects of N-arachidonoyl dopamine (N-ADA) in mice","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2026.115470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115470"}}